
Lactose (India) Ltd Falls to 52-Week Low of Rs 80 as Sell-Off Deepens
2026-03-23 13:45:47For the third consecutive session, Lactose (India) Ltd has seen its share price decline sharply, culminating in a fresh 52-week low of Rs 80 on 23 Mar 2026. This marks a 12.97% drop over the last three days, underscoring persistent selling pressure amid broader market weakness.
Read full news article
Lactose (India) Ltd Falls to 52-Week Low of Rs 83.5 as Sell-Off Deepens
2026-03-20 15:38:09For the second consecutive session, Lactose (India) Ltd has seen its share price decline sharply, hitting a fresh 52-week low of Rs 83.5 on 20 Mar 2026. This drop comes amid a broader market that is showing modest gains, highlighting a stark divergence for this pharmaceuticals micro-cap.
Read full news article
Lactose (India) Ltd is Rated Strong Sell
2026-03-13 10:10:29Lactose (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 March 2026, providing investors with the latest insights into the company’s performance and outlook.
Read full news article
Lactose (India) Ltd is Rated Strong Sell
2026-03-01 10:10:24Lactose (India) Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 13 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read full news articleAre Lactose (India) Ltd latest results good or bad?
2026-02-14 19:34:47Lactose (India) Ltd's latest financial results for Q3 FY26 reveal a complex scenario characterized by significant revenue growth juxtaposed with a sharp decline in profitability. The company reported net sales of ₹36.77 crores, reflecting a year-on-year growth of 28.03%, although this represents a sequential decline of 10.71% from the previous quarter. This topline expansion indicates strong demand for its pharmaceutical-grade lactose products, yet it has not translated into improved profitability. Net profit for the quarter fell to ₹0.53 crores, marking a substantial decline of 75.46% compared to the prior quarter. The operating margin, excluding other income, decreased to 8.35%, down 434 basis points from 12.75% in Q2 FY26, indicating a concerning trend of margin erosion. Additionally, the profit after tax (PAT) margin compressed to 1.44%, further underscoring the challenges faced in maintaining operatio...
Read full news article
Lactose (India) Q3 FY26: Profit Plunges 75% as Margin Pressures Mount
2026-02-14 08:47:14Lactose (India) Limited, a Gujarat-based pharmaceutical ingredients manufacturer, reported a sharp deterioration in profitability for Q3 FY26, with net profit collapsing 75.46% quarter-on-quarter to ₹0.53 crores from ₹2.16 crores in Q2 FY26. The ₹133-crore market capitalisation company's results revealed concerning margin compression despite modest revenue growth, triggering a bearish technical reversal that has pushed the stock down 32.55% over the past year.
Read full news articleAre Lactose (India) Ltd latest results good or bad?
2026-02-13 19:36:28Lactose (India) Ltd's latest financial results present a complex picture. For the quarter ending September 2025, the company reported a net profit of ₹2.16 crores, reflecting a significant quarter-on-quarter increase of 44.00% and a year-on-year increase of 6.40%. Revenue for the same period reached ₹41.18 crores, marking a year-on-year growth of 35.24% and a sequential improvement of 4.04%. This topline growth indicates a strengthening demand for Lactose's pharmaceutical and dairy product offerings. However, the operational efficiency metrics reveal challenges. The operating margin, excluding other income, contracted to 12.75% from 16.45% in the previous year, indicating a 370 basis points decline. This margin compression raises concerns about the company's ability to maintain profitability in the face of rising operational costs. The profit after tax (PAT) margin also showed a decline to 5.25%, down from...
Read full news article
Lactose (India) Ltd Upgraded to Sell on Technical Improvement Despite Fundamental Challenges
2026-02-13 08:02:38Lactose (India) Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 12 Feb 2026, driven primarily by improvements in its technical indicators despite ongoing fundamental challenges. The company’s Mojo Score now stands at 34.0, reflecting a cautious but slightly more optimistic stance amid mixed signals from valuation, financial trends, and quality metrics.
Read full news articleAnnouncement under Regulation 30 (LODR)-Newspaper Publication
27-Feb-2026 | Source : BSEPursuant to Regulation 30 and 47(3) of SEBI (LODR) Regulations 2015 we hereby submit the newspaper publication published in the newspaper of 27th February 2026 giving intimation of the notice of shareholders meeting being conducted under the directions of NCLT.
Shareholders Meeting Scheduled To Be Held On Saturday 28Th March 2026- Intimation For Book Closure And Instructions For Remote E-Voting
26-Feb-2026 | Source : BSEPursuant to Regulation 30 & 42 of SEBI (LODR) Regulations 2015 we hereby submit the intimation towards the Book closure remote e-voting.
Shareholders Meeting - By NCLT Scheduled To Be Convened On Saturday 28Th March 2026
26-Feb-2026 | Source : BSEPursuant to the NCLT order we hereby intimate under the Regulation 30 & 42 of SEBI (LODR) Regulations 2015 that the Extra Ordinary General Meeting of the Company is scheduled to be held on Saturday 28th March 2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
No Splits history available
No Bonus history available
No Rights history available






